9SL

[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate

Created:	2018-07-18
Last modified:	2024-09-27

Find Related PDB Entry
11 entries where 9SL is found as a standalone ligand1 entries where 9SL is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	38
Chiral Atom Count	3
Bond Count	40
Aromatic Bond Count	0

2D diagram of 9SL

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate
Synonyms	Saxitoxin
Systematic Name (OpenEye OEToolkits)	[(3~{a}~{S},4~{R},10~{a}~{S})-2,6-bis(azanyl)-10,10-bis(oxidanyl)-3~{a},4,8,9-tetrahydro-3~{H}-pyrrolo[1,2-c]purin-4-yl]methyl carbamate
Formula	C₁₀ H₁₇ N₇ O₄
Molecular Weight	299.286
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C132C(CCN1C(=NC(COC(=O)N)C2NC(=N3)N)N)(O)O
SMILES	CACTVS	3.385	NC(=O)OC[CH]1N=C(N)N2CCC(O)(O)[C]23N=C(N)N[CH]13
SMILES	OpenEye OEToolkits	2.0.6	C1CN2C(=NC(C3C2(C1(O)O)N=C(N3)N)COC(=O)N)N
Canonical SMILES	CACTVS	3.385	NC(=O)OC[C@@H]1N=C(N)N2CCC(O)(O)[C@@]23N=C(N)N[C@@H]13
Canonical SMILES	OpenEye OEToolkits	2.0.6	C1CN2C(=N[C@H]([C@H]3[C@]2(C1(O)O)N=C(N3)N)COC(=O)N)N
InChI	InChI	1.03	InChI=1S/C10H17N7O4/c11-6-15-5-4(3-21-8(13)18)14-7(12)17-2-1-9(19,20)10(5,17)16-6/h4-5,19-20H,1-3H2,(H2,12,14)(H2,13,18)(H3,11,15,16)/t4-,5-,10-/m0/s1
InChIKey	InChI	1.03	RPQXVSUAYFXFJA-HGRQIUPRSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL501134
PubChem	37165, 56947150
ChEMBL	CHEMBL501134
ChEBI	CHEBI:34970

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.